Taisho Pharmaceutical Co Ltd.

TYO:4535 ISIN:JP3442800003

Taisho Pharmaceutical Co Ltd. (TSE: 4535) is Japan's leading producer of over-the-counter (OTC) drugs, and the number two OTC drug manufacturer in the world. Taisho is currently endeavoring to strengthen its independent R&D capabilities in the field of prescription pharmaceuticals, and also aggressively pursuing tie-ups with both Japanese and overseas companies. 
 
   

查看其它语言版本

新闻

大正制药(TYO:4535)将以3.1亿美元收购百时美施贵宝(NYSE:BMY)的亚洲资产

🕔9/16/2009 3:19:31 PM 7260

日本的大正制药株式会社(TYO:4535) 周三表示，将收购百时美施贵宝公司（Bristol-Myers Squibb Co.）(NYSE:BMY) 在亚太地区（不包括中国和日本）价值3.1亿美元的非处方药业务。

阅读全文▸
###

14,412 公司背景浏览

  • 本页浏览人次: (过去7日: 7) (过去30日: 35) (自发布以来: 4840) 

公司详细信息